BEST SELLER
A passionate believer in preserving nature, Brad Pitt found his match in the Perrin Family: Both share the same love for the south of France “terroir” and the ambition to do what is right for nature. Both recognized that the vines and Provence had much to offer when it comes to skincare. Beau Domaine was born.
Born from The Perrin vineyards.
Formulated by world skin aging scientists.
Loved by Brad Pitt.
SIMPLE, EFFICIENT and effortless
— The Cleansing Emulsion in 100 ml
— The Serum in 30ml
— The Fluid Cream, The Rich Cream or The Cream in 50ml
Brad's Complete Routine
Our 3-step ritual
Which cream texture would you like to include in your routine?
Which version do you want?
As a cofounder of the brand, Brad Pitt was behind every stages of the products development.
The real test came when he started to use them: after a couple of days he became a convinced consumer.
He was totally win over by how easy and powerful it is to adopt as a daily routine.
Brad's Complete Routine
Our 3-step ritual
Which cream texture would you like to include in your routine?
Which version do you want?
Our proprietary science: 2 registered patents*, developed by leading scientists:
ProGR3®
GSM10®
97
%found their skin feeling clear, refreshed and soothed with The Cleansing Emulsion**
97
%feel that their skin is smoother with The Serum***
94
%found their skin smoother and more comfortable, with The Cream***
Brad saw results on his skin. Scientists proved the efficacy. Customers confirmed it.
** In vivo clinical test carried out under dermatological control on a panel of 32 women and men after 21 days
*** In vivo clinical test carried out dermatological control on a panel of 33 women and men after 28 days
Our ingredients come from one of the most unique land in the world: The South of France region.
The material we use, one of the most iconic plant: the vine of Provence.
Our methods, organic, nature preserving extraction, that gives back to nature everything we take from it.
*Patents registered:
N°EP22206512.8 (GSM10)
N°EP22315060.8 (ProGR3)
** In vivo clinical test carried out under dermatological control on a panel of 32 women and men after 21 days
*** In vivo clinical test carried out dermatological control on a panel of 33 women and men after 28 days